Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway

被引:62
|
作者
Gong, PF [1 ]
Cederbaum, AI [1 ]
Nieto, N [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
D O I
10.1074/jbc.M304728200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inducible form of heme oxygenase (HO-1) is increased during oxidative injury, and this may be an important defense mechanism against such injury. Cytochrome P450 2E1 (CYP2E1) generates reactive oxygen species and promotes lipid peroxidation. In this study induction of HO-1 by CYP2E1 and the possible role of mitogen-activated protein kinase ( MAPK) in this process were evaluated. HO-1 induction was observed in the livers of chronic alcohol-fed mice or pyrazole-treated rats, conditions known to elevate CYP2E1 levels. Increased levels of HO-1 were observed in HepG2 cells overexpressing CYP2E1 (E47 cells) compared with control HepG2 cells or HepG2 cells expressing CYP3A4. Expression of CYP2E1 in HepG2 cells transcriptionally activated the HO-1 gene, increasing HO-1 mRNA and protein expression and activity of a HO-1 reporter construct. CYP2E1 inhibitors and catalase blocked the increased production of reactive oxygen species as well as HO-1 induction. Increasing oxidative stress by the addition of arachidonic acid or depletion of glutathione further increased HO-1 induction. The phosphorylated form of ERK MAPK but not that of p38 or JNK MAPK was increased in E47 cells compared with the control C34 HepG2 cells. PD98059, a specific inhibitor of ERK MAPK, blocked the activity of a HO-1 reporter in E47 cells but not in C34 cells. These results suggest that increased CYP2E1 activity leads to induction of the HO-1 gene, and the ERK MAPK pathway is important in mediating this process. This induction may serve as an adaptive mechanism to protect the E47 cells against the CYP2E1-dependent oxidative stress.
引用
收藏
页码:29693 / 29700
页数:8
相关论文
共 50 条
  • [1] Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
    Gong, PF
    Hu, B
    Cederbaum, AI
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 432 (02) : 252 - 260
  • [2] Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
    Gong, PF
    Hu, B
    Cederbaum, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S35 - S35
  • [3] Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1
    Connick, J. Patrick
    Reed, James R.
    Cawley, George F.
    Backes, Wayne L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [4] Complex structure of NADPH-cytochrome P450 reductase and heme oxygenase-1
    Sugishima, M.
    Sato, H.
    Higashimoto, Y.
    Harada, J.
    Wada, K.
    Fukuyama, K.
    Noguchi, M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C478 - C478
  • [5] Inactivation of cytochrome P450 2E1 by capsaicin
    Smeal, SJ
    Reilly, CA
    Yost, GS
    FASEB JOURNAL, 2002, 16 (05): : A940 - A941
  • [6] Human and minipig cytochrome P450 2E1
    Baranová, J
    Anzenbacherová, E
    Zuber, R
    Anzenbacher, P
    Soucek, P
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 143 - 147
  • [7] Hepatic cytochrome p450 2E1 is increased in patients with nonalcoholic steatohepatitis
    Weltman, MD
    Farrell, GC
    Hall, P
    Ingelman-Sundberg, M
    Liddle, C
    HEPATOLOGY, 1998, 27 (01) : 128 - 133
  • [8] Heme oxygenase-1 protects HEPG2 cells against cytochrome P450 2E1-dependent toxicity
    Gong, PF
    Cederbaum, AI
    Nieto, N
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (03) : 307 - 318
  • [9] Occupational toluene exposure induces cytochrome P450 2E1 mRNA expression in peripheral lymphocytes
    Mendoza-Cantú, A
    Castorena-Torres, F
    de León, MB
    Cisneros, B
    López-Carrillo, L
    Rojas-García, AE
    Aguilar-Salinas, A
    Manno, M
    Albores, A
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2006, 114 (04) : 494 - 499
  • [10] Functional characterization and tissue expression of marmoset cytochrome P450 2E1
    Uehara, Shotaro
    Uno, Yasuhiro
    Tomioka, Etsuko
    Inoue, Takashi
    Sasaki, Erika
    Yamazaki, Hiroshi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (06) : 394 - 397